NEUROCRINE BIOSCIENCES INC

NBIX · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $13.3B · 2,000 employees
157
SEC Filings
$155.64
Close 2026-09-04
2,000
Employees

Business Summary

Neurocrine Biosciences is a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and commercializing treatments for neurological, psychiatric, endocrine, and immunological disorders. Its commercial products include INGREZZA (valbenazine) for tardive dyskinesia and Huntington's disease chorea, and CRENESSITY (crinecerfont) for classic congenital adrenal hyperplasia. INGREZZA generated $2.51 billion in net product sales in 2025. The company also collaborates with AbbVie on elagolix for endometriosis and uterine fibroids, and maintains a pipeline of late- and early-stage candidates including osavampator and direclidine.

Latest Stock Quote

NBIX 2026-09-04 $155.64 O:$158.24 H:$159.7999 L:$154.83 Vol:0.9M VWAP:$155.9855
origin leaf: null

Next Earnings

expected 2026-10-29

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-112025-12-310000914475-26-000007EDGAR65K words
2025-02-102024-12-310000914475-25-000037EDGAR62K words
2024-02-092023-12-310000914475-24-000054EDGAR60K words
2023-02-092022-12-310000914475-23-000011EDGAR—
2022-02-112021-12-310000914475-22-000013EDGAR—
2021-02-052020-12-310000914475-21-000020EDGAR—
2020-02-072019-12-310001564590-20-003773EDGAR—
2019-02-082018-12-310001564590-19-002328EDGAR—
2018-02-132017-12-310001193125-18-042794EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-07-312026-06-300000914475-26-000037EDGAR44K words
2025-10-282025-09-300000914475-25-000181EDGAR38K words
2025-07-302025-06-300000914475-25-000158EDGAR38K words
2025-05-052025-03-310000914475-25-000100EDGAR36K words
2024-10-302024-09-300000914475-24-000211EDGAR34K words
2024-08-012024-06-300000914475-24-000181EDGAR34K words
2024-05-012024-03-310000914475-24-000117EDGAR33K words
2023-10-312023-09-300000914475-23-000073EDGAR38K words
2023-08-012023-06-300000914475-23-000057EDGAR37K words
2023-05-032023-03-310000914475-23-000044EDGAR—
2022-11-012022-09-300000914475-22-000058EDGAR—
2022-08-042022-06-300000914475-22-000044EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-07-300000914475-26-000035EDGAR6K words
2026-04-060001193125-26-142904EDGAR67K words
2026-02-110000914475-26-000006EDGAR5K words
2025-11-240000914475-25-000186EDGAR1K words
2025-10-280000914475-25-000180EDGAR5K words
2025-07-300000914475-25-000157EDGAR5K words
2025-05-300000914475-25-000139EDGAR12K words
2025-05-220000914475-25-000120EDGAR1K words
2025-05-050000914475-25-000099EDGAR4K words
2025-04-040000914475-25-000081EDGAR1K words

157 total filings indexed. 126 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ARGX — ARGENX SE

Tags

tardive-dyskinesia huntington's-disease-chorea classic-congenital-adrenal-hyperplasia endometriosis uterine-fibroids major-depressive-disorder schizophrenia bipolar-mania alzheimer's-disease epilepsy dystonia-and-movement-disorders neurology psychiatry endocrinology immunology current-good-manufacturing-practice-(cgmp)

Company Identity

CIK0000914475
TickerNBIX
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE
Websitehttps://www.neurocrine.com
Listed1996-05-23

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 31bd010aa4c0c0f4fcd7e7491227423fe81bbd7242f9b098fa3cc8addc8bbfc8
parent: 3cfcbec711a7b776e94efe9f7579f7f6fe0d3cff3041e8fcdfa293d51043d70a
content hash: 31ebb00d3eaaaabfab08e264c1870b791c7988d9451eb019b3b45ff5374293b9
signed: 2026-09-28T19:02:18.278Z
sources: 21 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up NBIX using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on NBIX, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/NBIX (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.